Red Cell Antibody Screening in Pregnancy: A Preliminary Insight?
Antibody Screening in Pregnancy
Vol. 7 No. 1 : 2012 (41-46)
Abstract
Red cell alloimmunisation is defined as the development of antibodies in response to foreign red cell antigens through transfusion or pregnancy. In pregnant women even without the history of previous blood transfusion, this is possible through previous or current pregnancy with the presence of paternal red cell antigen inherited by the fetus. This study was aimed to determine the prevalence of red cell alloimmunisation among pregnant women without previous history of blood transfusion and the association with number of pregnancy and history of obstetric complications. This was a cross-sectional study in which 150 pregnant women were randomly selected from the antenatal clinic. Ten mls of peripheral blood was obtained for antibody screening using indirect antiglobulin test besides the routine antenatal screening. In this study, the majority (37.3%) of the women were primigravidae. Red cell alloantibodies were detected in two out of 150 (1.3%) patients which were subsequently identified as anti-C and anti-D. However none of the primigravida was alloimmunised. One woman of gravida 2 (2.9%) and gravida 3 (3.6%) each were positive for alloimmunisation. One of them also had a bad obstetric history. This study showed that the prevalence of red cell alloimmunisation among pregnant women was low in this centre. Nevertheless, red cell alloantibody screening test should be made available to reduce possible complications of alloimmunisation in mothers and fetuses.
Keywords :
alloimmunisation,
pregnancy,
red cell antibody,
screening,
Correspondance Address
Dr. Suria Abdul Aziz, Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaakob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur.
Tel: 603-91455443 Fax: 603-91456676. Email: suria.abdulaziz@gmail.com
References
British Committee for Standards in Haematology. 2006. Blood Transfusion Task Force. Guidelines for blood grouping and antibody testing in pregnancy.
Denise, M.H. 2005. Modern blood banking and transfusion practices. 5th edition. Philadelphia: F.A. Davis Company; 383-388.
Howard, H., Martlew, V., McFaden, I., Clarke, C., Duguid, J., Bromilow, I., & Eggington. J. 1998. Consequences for fetus and neonate of maternal red cell alloimmunization. Arch Dis Child Fetal Neonatal Ed 78(1): F62-66.
Lee, C.K., Ma, E.S.K., Tang, M., Lam, C.C.K., Lin, C.K., & Chan, L.C. 2003. Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy-a review of cases from 1997-2001. Transfus Med 13(4): 227-231.
Lobo, G.A.R., Nardozza, L.M.M., Camano, L. 2006. Non-anti-D antibodies in red cell alloimmunization. Int J Gynecol Obstet 94(2):139-140.
Moise Jr, K.J. 2000. Non anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 92(1):75-81.
Patel, J., Shukla, R., Gupte, S. 2009. Red Cell Alloimmunization in Multitransfused Patients and Multiparous Women. Indian J Hematol Blood Transfus 25(2):49-52
Roback, J.D., Combs, M.R., Grossman, B.J., Hillyer, C.D. 2008. Technical Manual AABB. 16th edition. Bethesda: AABB; 625-633.
Shanwell, A., Sallander, S., Bremme, K., Westgren, M. 1999. Clinical evaluation of a solid phase test for red cell antibody screening of pregnant women. Transfusion 39(1):26-31.
Solola, A., Sibai, B. & Mason, J.M. 1983. Irregular antibodies: an assessment of Routine Prenatal Screening. Obstet Gynecol 61(1): 25-30
Weinstein, l. 1982. Irregular antibodies causing hemolytic disease of the newborn: a continuing problem. Clin Obstet Gynecol 25(2):321-332.
Yousuf, R., Suria, A.A., Nurasyikin, Y., Leong, C.F. 2012, Incidence of Red Cell Alloantibody among the Transfusion Recipients of Universiti Kebangsaan Malaysia Medical Centre. Indian Journal of Hematology and Blood Transfusion. Online First, 25th April 2012
